Article
Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia.
Journal of inherited metabolic disease - 1 Aug 2007
Gramer G, Burgard P, Garbade S F, Lindner M
Abstract excerpt
In recent years several studies on tetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency have been published. The molecular mechanisms of BH4 responsiveness are not conclusively understood, but there is evidence that BH4 responsiveness in hyperphenylalaninaemia (HPA) depends on the patient's genotype and residual PAH activity. As a BH4 preparation will soon obtain marketing approval as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
